爱唯医学网 | 资讯 | 期刊 | 血液病学学术中心
登录 | 注册
经国际骨髓瘤工作组(IMW)授权,由西安杨森制药有限公司学术赞助,爱唯医学网(www.Elseviermed.cn)引进了2015年IMW会议课程,总计61套中英文双语在线课程,61套课件概要,同时邀请到中国血液肿瘤领域知名专家针对热门课程进行点评。同时所有课程均可以在目前主流移动终端(iPad,iPhone以及大部分Andriod终端)顺利播放,方便您随时随地学习骨髓瘤领域的最前沿信息。
Biomarker to change Therapy MRD/Imaging vs FISH/Age -‐ in Favor of MRD/Imaging 改变治疗的生物标志: 微小残留病/影像学 vs FISH/年龄-赞成前者
Biomarker to change Therapy MRD/Imaging vs FISH/Age -‐ in Favor of FISH/Age 改变治疗的生物标志: 微小残留病/影像学 vs FISH/年龄-赞成后者
New Diagnostic Criteria for Multiple Myeloma 多发性骨髓瘤的新诊断标准
Flow Cytometry for Minimal Residual Disease 流式细胞术用于微小残留病检测
Next Generation Sequencing for Minimal Residual Disease 下一代测序用于微小残留病检测
Imaging Techniques 影像学技术
Risk Assessment and Stratification 风险评估和分层
Geriatric Assessment and Stratification 老年患者评估和分层
Smoldering Multiple Myeloma 冒烟型多发性骨髓瘤
OP-001 A Meta-Analysis Investigating the Impact of Minimal Residual Disease (MRD) Status on Survival Outcomes in Patients with Multiple Myeloma (MM) who Achieve Complete Response (CR) OP-001 获得完全缓解的多发性骨髓瘤患者中微小残留病状态对生存结局影响的荟萃分析研究
The Vk*MYC mouse model to study drug and immunotherapy response and resistance 使用Vk*MYC 小鼠模型研究药物、免疫疗法应答和抵抗
Multiple Myeloma Biological Pathways 多发性骨髓瘤生物学通路
Multiple Myeloma and the bone marrow niche 多发性骨髓瘤和骨髓微环境
Next Generation Sequencing 下一代测序
Gene Expression Profile 基因表达谱
SNP/microRNA SNP/microRNA
RS-001 Hedgehog Pathway over Expression Identifies Myeloma Patients with worse Prognosis RS-001 Hedgehog通路过表达识别预后较差的骨髓瘤患者
RS-002 Preclinical Analysis of Feasibility and Efficacy of CS1 Directed CAR T cell Therapy in Multiple Myeloma in the Autologous Setting RS-002 CS 1定向CAR-T细胞疗法用于自体同源移植条件下多发性骨髓瘤患者的可行性和有效性临床前分析
RS-003 Carfilzomib and Dexamethasone in Untreated Symptomatic Multiple Myeloma RS-003 卡非佐米和地塞米松治疗未经治疗的症状性多发性骨髓瘤
RS-004 Ribosomal Dysfunction in AL Amyloidosis: Gene Expression Profile Meta-Analysis RS-004 AL淀粉样变性中的核糖体功能障碍:基因表达谱荟萃分析
精选课题专家点评 针对IWM 2015的精选课题,特邀请国内血液病领域专家邱录贵教授、侯健教授、蔡真教授、路瑾教授等进行精彩点评。